Your browser doesn't support javascript.
loading
Poly - (l) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
Apfelthaler, C; Anzengruber, M; Gabor, F; Wirth, M.
Afiliação
  • Apfelthaler C; Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. Electronic address: christina.apfelthaler@univie.ac.at.
  • Anzengruber M; Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. Electronic address: maria.anzengruber@gmx.at.
  • Gabor F; Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. Electronic address: franz.gabor@univie.ac.at.
  • Wirth M; Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. Electronic address: michael.wirth@univie.ac.at.
Eur J Pharm Biopharm ; 115: 131-139, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28237713
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polímeros / Neoplasias da Bexiga Urinária / Aglutininas do Germe de Trigo / Preparações Farmacêuticas / Ácido Glutâmico Idioma: En Revista: Eur J Pharm Biopharm Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polímeros / Neoplasias da Bexiga Urinária / Aglutininas do Germe de Trigo / Preparações Farmacêuticas / Ácido Glutâmico Idioma: En Revista: Eur J Pharm Biopharm Ano de publicação: 2017 Tipo de documento: Article